Results 111 to 120 of about 10,072 (202)

Evaluation of the DNA Alkylation Properties of a Chlorambucil‐Conjugated Cyclic Pyrrole‐Imidazole Polyamide [PDF]

, 2020
Yuki Hirose, Kaori Hashiya, Toshikazu Bando, Hiroshi Sugiyama   +3 more
openalex   +1 more source

Correction: Efficacy and safety in a 4-year follow-up of the ELEVATE-TN study comparing acalabrutinib with or without obinutuzumab versus obinutuzumab plus chlorambucil in treatment-naïve chronic lymphocytic leukemia. [PDF]

Leukemia
Sharman JP, Egyed M, Jurczak W, Skarbnik A, Pagel JM, Flinn IW, Kamdar M, Munir T, Walewska R, Corbett G, Fogliatto LM, Herishanu Y, Banerji V, Coutre S, Follows G, Walker P, Karlsson K, Ghia P, Janssens A, Cymbalista F, Woyach JA, Ferrant E, Wierda WG, Munugalavadla V, Yu T, Wang MH, Byrd JC.   +26 more
europepmc   +1 more source

Comparative Efficacy of Ibrutinib Versus Obinutuzumab + Chlorambucil in First-Line Treatment of Chronic Lymphocytic Leukemia: A Matching-Adjusted Indirect Comparison [PDF]

, 2017
Suzy Van Sanden, Simona Baculea, Joris Diels, Sarah Côté   +3 more
openalex   +1 more source

Sequence-Specific DNA Alkylation and Transcriptional Inhibition by Long-Chain Hairpin Pyrrole–Imidazole Polyamide–Chlorambucil Conjugates Targeting CAG/CTG Trinucleotide Repeats [PDF]

, 2020
Sefan Asamitsu
openalex   +1 more source

Cost-effectiveness of acalabrutinib monotherapy or with obinutuzumab versus chemoimmunotherapy for untreated chronic lymphocytic leukemia in China. [PDF]

Ther Adv Hematol
Li M, Zhong X, Zhang C, Luo H, Luo L, Huang Y, Jiang L.   +6 more
europepmc   +1 more source

The clinical pharmacology of chlorambucil and prednimustine [letter] [PDF]

British Journal of Clinical Pharmacology, 1983
Newell, AH Calvert, TJ McElwain, KR Harrap   +3 more
openaire   +3 more sources

Initial chemotherapy with mitoxantrone, chlorambucil, prednisone impairs the collection of stem cells in patients with indolent lymphomas—results of a randomized comparison by the German Low-Grade Lymphoma Study Group

, 2006
Christina Nickenig, M. Dreyling, Eva Hoster, Wolfgang Ludwig, Bernd Dörken, Mathias Freund, Christoph Huber, Arnold Ganser, Lorenz Trümper, Roswitha Forstpointner, Michael Unterhalt, W. Hiddemann   +11 more
openalex   +1 more source

Prognostic value of MRD in CLL patients with comorbidities receiving chlorambucil plus obinutuzumab or rituximab [PDF]

, 2018
Anton W. Langerak, Matthias Ritgen, Valentin Goede, Sandra Robrecht, Jasmin Bahlo, Kirsten Fischer, Michael Steurer, Marek Trněný, Stephen P. Mulligan, Ulrich Mey, Kerstin Trunzer, Günter Fingerle‐Rowson, Kathryn Humphrey, Stephan Stilgenbauer, Sebastian Böttcher, Monika Brüggemann, Michael Hallek, Michael Kneba, Jacques J. M. van Dongen   +18 more
openalex   +1 more source

Evaluation of the antiproliferative, cytotoxic and phytochemical properties of Zimbabwean medicinal plants used in cancer treatment. [PDF]

BMC Complement Med Ther
Mlilo S, Sibanda S, Sithole S, Mukanganyama S, Naik YS.   +4 more
europepmc   +1 more source

Frontline treatment of chronic lymphocytic leukemia with obinutuzumab and chlorambucil: how does it work in “real‑life”? [PDF]

, 2018
Valentin Goede
openalex   +1 more source